Metabolomic profiling reveals novel biomarkers of alcohol intake and alcohol-induced liver injury in community-dwelling men

Environmental Health and Preventive Medicine

Volumn 21, Issue 1, 2016, Pages 18-26

  Harada, Sei ^a   Takebayashi, Toru ^a   Kurihara, Ayako ^a   Akiyama, Miki ^a   Suzuki, Asako ^a   Hatakeyama, Yoko ^a   Sugiyama, Daisuke ^a   Kuwabara, Kazuyo ^a   Takeuchi, Ayano ^a   Okamura, Tomonori ^a   Nishiwaki, Yuji ^b   Tanaka, Taichiro ^b   Hirayama, Akiyoshi ^a   Sugimoto, Masahiro ^a   Soga, Tomoyoshi ^a   Tomita, Masaru ^a  

^a KEIO UNIVERSITY   (Japan)

^b TOHO UNIVERSITY   (Japan)

Author keywords

Alcohol; Alcoholic liver disease; Amino acids; Biomarker; Metabolomics

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; GAMMA GLUTAMYLTRANSFERASE; GLUTAMIC ACID; GLUTAMINE; GUANIDINOSUCCINIC ACID; LIVER ENZYME; THREONINE;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; AMINO ACID METABOLISM; ARTICLE; BLOOD LEVEL; CAPILLARY ELECTROPHORESIS; COMMUNITY LIVING; CROSS-SECTIONAL STUDY; DIET RESTRICTION; FEMALE; HUMAN; JAPANESE (PEOPLE); LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MEASUREMENT; METABOLOME; METABOLOMICS; BLOOD; DRINKING BEHAVIOR; JAPAN; LIVER DISEASES, ALCOHOLIC; MIDDLE AGED;

ADULT; AGED; ALCOHOL DRINKING; BIOMARKERS; CROSS-SECTIONAL STUDIES; ELECTROPHORESIS, CAPILLARY; FEMALE; HUMANS; JAPAN; LIVER DISEASES, ALCOHOLIC; MALE; MASS SPECTROMETRY; METABOLOME; MIDDLE AGED;

EID: 84952870164     PISSN: 1342078X     EISSN: 13474715     Source Type: Journal    
DOI: 10.1007/s12199-015-0494-y     Document Type: Article

References (32)

1. Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol. 2013;59:160–8.
2. World Health Organization. Global status report on alcohol and health 2014. Geneva: World Health Organization; 2014 (cited 2015 July 17). http://www.who.int/substance_abuse/publications/global_alcohol_report/msb_gsr_2014_1.pdf?ua=1.
3. Lutz NW, Sweedler JV, Wevers RA. Methodologies for metabolomics: experimental strategies and techniques. Cambridge: Cambridge University Press; 2013.
4. Issaq HJ, Van QN, Waybright TJ, Muschik GM, Veenstra TD. Analytical and statistical approaches to metabolomics research. J Sep Sci. 2009;32:2183–99.
5. Suhre K, Shin S, Petersen A. Human metabolic individuality in biomedical and pharmaceutical research. Nature. 2011;477:54–60.
6. Warren KR, Murray MM. Alcoholic liver disease and pancreatitis: global health problems being addressed by the US National Institute on Alcohol Abuse and Alcoholism. J Gastroenterol Hepatol. 2013;28(Suppl 1):4–6.
7. Jaremek M, Yu Z, Mangino M, Mittelstrass K, Prehn C, Singmann P, et al. Alcohol-induced metabolomic differences in humans. Transl Psychiatry. 2013;3:e276.
8. Lieber CS. Role of oxidative stress and antioxidant therapy in alcoholic and nonalcoholic liver diseases. Adv Pharmacol. 1997;38:601–28.
9. Zakhari S, Li TK. Determinants of alcohol use and abuse: impact of quantity and frequency patterns on liver disease. Hepatology. 2007;46:2032–9.
10. Kharbanda KK. Methionine metabolic pathway in alcoholic liver injury. Curr Opin Clin Nutr Metab Care. 2013;16:89–95.
11. van der Werf MJ, Overkamp KM, Muilwijk B, Coulier L, Hankemeier T. Microbial metabolomics: toward a platform with full metabolome coverage. Anal Biochem. 2007;370:17–25.
12. Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics. 2010;6:78–95.
13. Soga T, Igarashi K, Ito C, Mizobuchi K, Zimmermann H-P, Tomita M. Metabolomic profiling of anionic metabolites by capillary electrophoresis mass spectrometry. Anal Chem. 2009;81:6165–74.
14. Ramautar R, Somsen GW, de Jong GJ. CE-MS in metabolomics. Electrophoresis. 2009;30:276–91.
15. Okamura T, Tanaka T, Yoshita K, Chiba N, Takebayashi T, Kikuchi Y, et al. Specific alcoholic beverage and blood pressure in a middle-aged Japanese population: the High-risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) Study. J Hum Hypertens. 2004;18:9–16.
16. Hirayama A, Nakashima E, Sugimoto M, Akiyama S, Sato W, Maruyama S, et al. Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy. Anal Bioanal Chem. 2012;404:3101–9.
17. Hirayama A, Kami K, Sugimoto M, Sugawara M, Toki N, Onozuka H, et al. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res. 2009;69:4918–25.
18. Gardner CD, Tribble DL, Young DR, Ahn D, Fortmann SP. Associations of HDL, HDL(2), and HDL(3) cholesterol and apolipoproteins A-I and B with lifestyle factors in healthy women and men: the Stanford Five City Project. Prev Med. 2000;31:346–56.
19. Brinton EA. Effects of ethanol intake on lipoproteins. Curr. Atheroscler Rep. 2012;14:108–14.
20. Tanaka H, Ikai E, Yamada Y. Genetic polymorphisms in alcohol metabolizing enzymes as related to sensitivity to alcohol-induced health effects. Environ Health Prev Med. 1997;1:193–200.
21. Yamada Y, Noborisaka Y, Ishizaki M, Tsuritani I, Honda R. Low fasting serum insulin in Japanese alcohol consumers does not imply improved coronary risk factors. Environ Health Prev Med. 2004;9:243–50.
22. Nakamura S, Ito Y, Suzuki K, Hashimoto S. Blood pressure, levels of serum lipids, liver enzymes and blood glucose by aldehyde dehydrogenase 2 and drinking habit in Japanese men. Environ Health Prev Med. 2006;11:82–8.
23. Tominaga T, Suzuki H, Mizuno H, Kouno M, Suzuki M, Kato Y, et al. Clinical significance of measuring plasma concentrations of glutamine and glutamate in alcoholic liver diseases. Alcohol Alcohol Suppl. 1993;1A:103–9.
24. Reichling JJ, Kaplan MM. Clinical use of serum enzymes in liver disease. Dig Dis Sci. 1988;33:1601–14.
25. Jones DP, Carlson JL, Mody VC, Cai J, Lynn MJ, Sternberg P. Redox state of glutathione in human plasma. Free Radic Biol Med. 2000;28:625–35.
26. Kleinman WA, Richie JP. Status of glutathione and other thiols and disulfides in human plasma. Biochem Pharmacol. 2000;60:19–29.
27. Medici V, Peerson JM, Stabler SP, French SW, Gregory JF, Virata MC, et al. Impaired homocysteine transsulfuration is an indicator of alcoholic liver disease. J Hepatol. 2010;53:551–7.
28. Musshoff F, Daldrup T. Determination of biological markers for alcohol abuse. J Chromatogr B Biomed Sci Appl. 1998;713:245–64.
29. Darling PB, Grunow J, Rafii M, Brookes S, Ball RO, Pencharz PB. Threonine dehydrogenase is a minor degradative pathway of threonine catabolism in adult humans. Am J Physiol Endocrinol Metab. 2000;278:E877–84.
30. Peng H, Chen Y, Chen J. Effects of glutamine administration on inflammatory responses in chronic ethanol-fed rats. J Nutr Biochem. 2011;22:282–8.
31. Marescau B, De Deyn PP, Holvoet J, Possemiers I, Nagels G, Saxena V, et al. Guanidino compounds in serum and urine of cirrhotic patients. Metabolism. 1995;44:584–8.
32. Sampson JN, Boca SM, Shu XO, Stolzenberg-Solomon RZ, Matthews CE, Hsing AW, et al. Metabolomics in epidemiology: sources of variability in metabolite measurements and implications. Cancer Epidemiol Biomark Prev. 2013;22:631–40.